Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M89,324Revenue (TTM) $M19,965Net Margin (%)24.2Altman Z-Score5.8
Enterprise Value $M91,768EPS (TTM) $2.9Operating Margin %24.1Piotroski F-Score6
P/E(ttm)18.8Beneish M-Score-2.5Pre-tax Margin (%)31.1Higher ROA y-yY
Price/Book6.210-y EBITDA Growth Rate %-1.1Quick Ratio1.4Cash flow > EarningsN
Price/Sales4.55-y EBITDA Growth Rate %-4.5Current Ratio1.6Lower Leverage y-yN
Price/Free Cash Flow34.0y-y EBITDA Growth Rate %147ROA % (ttm)14.7Higher Current Ratio y-yY
Dividend Yield %2.8PEG--ROE % (ttm)32.0Less Shares Outstanding y-yY
Payout Ratio %53.0Shares Outstanding M1,647ROIC % (ttm)22.1Gross Margin Increase y-yN

Gurus Latest Trades with BMY

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

BMY is held by these investors:



BMY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ANDREOTTI LAMBERTODirector 2017-04-07Sell34,000$53.261.58view
ANDREOTTI LAMBERTODirector 2017-03-28Sell34,000$56.17-3.69view
Schmukler Louis SPres., Global Mfg. & Supply 2017-03-17Sell5,000$56.49-4.23view
Caldarella Joseph CSVP & Controller 2017-03-15Sell8,096$57.29-5.57view
Schmukler Louis SPres., Global Mfg. & Supply 2017-03-14Sell15,000$56.75-4.67view
LEUNG SANDRAEVP, General Counsel 2017-03-06Sell92,405$57.02-5.12view
Samuels Theodore R. IIDirector 2017-02-27Buy12,000$56.77-4.7view
ANDREOTTI LAMBERTODirector 2016-09-08Sell21,600$56.87-4.87view
ANDREOTTI LAMBERTODirector 2016-08-25Sell23,200$59.17-8.57view
ANDREOTTI LAMBERTODirector 2016-07-08Sell23,200$74.45-27.33view

Press Releases about BMY :

Quarterly/Annual Reports about BMY:

News about BMY:

Articles On GuruFocus.com
Top 5 Buys of Market-Trouncing Firm Primecap Management May 19 2017 
Merck Collaborates With OncoSec Medical to Unlock Untapped Market for Keytruda May 10 2017 
Bristol-Myers Squibb and Calithera Biosciences Expand Collaboration Evaluating Opdivo (nivolumab) in May 10 2017 
Eaton Vance Worldwide Health Sciences Fund 1st Quarter Investment Report May 02 2017 
Bristol-Myers Squibb: Strong Earnings Could Warrant Higher Dividend Growth Ahead Apr 28 2017 
The Mutual Fund That Is a Top 10 Guru Apr 05 2017 
Weekly Top Insider Buys Highlight for the Week of March 3 Mar 04 2017 
David Tepper Invests Heavily in Pharma in 4th Quarter Feb 16 2017 
Baron Funds' Fifth Avenue Growth Fund Comments on Bristol-Myers Squibb Company Feb 13 2017 
Dodge & Cox Comments on Bristol-Myers Squibb Feb 01 2017 

More From Other Websites
Blog Coverage: Bristol-Myers Squibs Received EMA Validation of Sprycel for the Treatment in Children... May 22 2017
What Orencia Meant to BMY in 1Q17 May 22 2017
New Research Reports for Britol-Myers, Pricline & Phillips 66 May 19 2017
Top 5 Buys of Market-Beating Investors at Primecap Management May 19 2017
Behind BMY’s Cardiovascular Performance in 1Q17 May 19 2017
Revisiting Bristol-Myers Squibb’s Virology in 1Q17 May 19 2017
European Medicines Agency Validates Application for Bristol-Myers Squibb’s Sprycel (dasatinib) in... May 19 2017
What Happened to Bristol-Myers Squibb’s Opdivo in 1Q17? May 19 2017
The Hot Stock: Incyte Climbs May 18 2017
Understanding Bristol-Myers Squibb’s Oncology Performance in 1Q17 May 18 2017
Biotech Movers: Fast Track Designation Sends Sage Shares Higher May 18 2017
Behind Bristol-Myers Squibb’s 1Q17 Performance May 18 2017
Inside Bristol-Myers Squibb’s Valuation after the 1Q17 Earnings May 18 2017
What to watch at ASCO cancer conference May 18 2017
Bristol-Myers Squibb Research Showcases Expansive Oncology Clinical Development Program and... May 17 2017
Eli Lilly: Worries Ahead In Patent Fight May 17 2017
Cramer: Carl Icahn Was Right to Sell Apple at $95 May 16 2017
Eli Lilly: Has This Bloom Begun To Wilt? May 16 2017
Bristol-Myers Squibb to Take Part in UBS Global Healthcare Conference May 16 2017
Retired? 3 Stocks You Should Consider Buying May 14 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat